Sign in
4

Changes in Ownership

TREACE MEDICAL CONCEPTS, INC. Filed Acc 0001209191-24-001589

Chief Innovation Officer acquired 65,025 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Scanlan Sean F. · Chief Innovation Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-10 Grant or award : show line 1 in the form +65,025 97,209 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-01-10 Grant or award : show line 2 in the form Stock Option (Right to Buy) +73,200 $13.46 2034-01-10 73,200 73,200 D
Loading xslF345X05/doc4.xml…